Gummy Supplements Boom as Sales Hit $66.8B by 2031—But Do They Work?

The gummy supplements market is expanding rapidly, with sales jumping from $24.3 billion in 2023 to a projected $66.8 billion by 2031. This growth reflects a shift in consumer habits, as more people opt for chewable, flavoured alternatives over traditional pills. Yet not all products deliver what they promise—recent tests revealed some top-selling creatine gummies contained little to no active ingredient.

Online sales of gummy supplements surged by 29% last year, fuelled by direct-to-consumer brands, wellness influencers, and subscription services. Vitamin-based gummies dominate the sector, accounting for 48% of global sales. Meanwhile, plant-based pectin gummies—free from gelatin—grew by 22%, as buyers increasingly seek vegan, sugar-free, and non-GMO options.

The market's appeal has attracted investment, with companies like Grüns raising $35 million in Series B funding, pushing its valuation to $500 million. This trend extends beyond vitamins, as creatine supplement makers now explore chewable formats to tap into the same convenience-driven demand. Industry data shows 70% of global consumers now prefer chewable or flavoured supplements over traditional pills.

However, quality concerns persist. A recent investigation found that Amazon's top-rated creatine gummies contained almost none of the advertised muscle-boosting compound. Despite this, the overall market continues to grow at a compounded annual rate of 13.6% through 2031.

The gummy supplement industry is on track to more than double in size by 2031, driven by convenience and shifting consumer preferences. While demand for plant-based, label-conscious products rises, inconsistencies in product quality remain a challenge. The sector's expansion suggests chewable formats will play an even larger role in the future of dietary supplements.